NDAORALTABLET
Approved
Dec 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
6
Mechanism of Action
unclear; however, its effect could be related to its interaction with GABA-receptor complexes at binding domains located close to or allosterically coupled to benzodiazepine receptors.
Indications (1)
Clinical Trials (5)
Investigation of the Safety and Efficacy of Long Term Administration of Eszopiclone in Insomnia Patients
Started Oct 2012
438 enrolled
Insomnia
Investigation of the Safety and Efficacy of Eszopiclone in Insomnia Patients
Started Oct 2012
4,876 enrolled
Insomnia
A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150)
Started Oct 2008
369 enrolled
Insomnia
A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)
Started Sep 2008
192 enrolled
Primary Insomnia
An Evaluation of Potential Next-day Residual Effects of Eszopiclone in Healthy Volunteers.
Started Jul 2008
91 enrolled
Healthy SubjectsSleep Initiation and Maintenance Disorders